CALR and infection: Therefore, although bacterial burden and histopathological improvement provide preliminary support for the therapeutic potential of calreticulin, further studies incorporating extended observation periods, multiple infection doses, and dynamic clinical scoring systems are needed to comprehensively validate its protective efficacy and safety.